Concepedia

CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment

Giulio Metro, Gianluigi Lunardi, Piero Floridi, Jennifer Paola Pascali, Luca Marcomigni, Rita Chiari, Vienna Ludovini, Lucio Crinò, Stefania Gori

Journal of Thoracic Oncology · 2015 · 109 citations · 4 references

DOIFull text

Open access

Concepts

References

4

Clinical Experience With Crizotinib in Patients With Advanced <i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

Daniel B. Costa, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2015 · 605 citations · Full text

, , +14

CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib

Daniel B. Costa, Susumu Kobayashi, Shuchi S. Pandya et al. · Journal of Clinical Oncology · 2011 · 590 citations · Full text

, , +17

Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier

Hans‐Joachim Stemmler, Manfred Schmitt, Amina Willems et al. · Anti-Cancer Drugs · 2006 · 411 citations

, , +17

Determination of crizotinib in human and mouse plasma by liquid chromatography electrospray ionization–tandem mass spectrometry (LC-ESI–MS/MS)

Michael S. Roberts, David C. Turner, Alberto Broniscer et al. · Journal of Chromatography B · 2014 · 33 citations · Full text

, , +13